The Tools You Need to Accelerate Rare Disease Drug Development
Did you know that February 28th is Rare Disease Day?
If you’re on the journey to address rare disease with orphan drug development, you’re not alone. We’re here to support you! Certara’s tech-driven services address key challenges in developing drugs for rare diseases including clinical, regulatory, and commercial aspects. That’s why this month, we’re sharing our top pieces studies that provide insights from experts.
VIDEO: The Tools You Need to Accelerate Rare Disease Drug Development
ARTICLE: Exceling at Accelerating in Rare Disease Drug Development
By Rajesh Krishna, PhD, and Steve Sibley
BLOG: Will the Inflation Reduction Act Impact Drug Development Decisions?
By Steve Sibley
CASE STUDY: Simcyp Simulator Helps Optimize Drug Dosing in Adults & Adolescents with Orphan Disease
领英推荐
WHITE PAPER: The Challenges and Opportunities of Rare Disease Drug Development
SERVICES: Rare Disease & Orphan Drug Development Resource Center
?Register now to attend live scientific webinars
Where to find Certara this?Winter
Enjoying the Inner Circle? Don't forget to?subscribe?at the top.??
Want to share? Click share below.
Have questions about our services and software??Contact us.
About Certara
Certara?accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.
Corporate Headquarters: 100 Overlook Center, Suite 101, Princeton, NJ 08540 USA
Tech Engineer @Human Body | Junior Resident Doctor @ AIIMS Bhubaneswar | Medtech & Biotech Startup Enthusiast
1 年Very enriching ??